Cargando…
Prognostic Factors for Short‐term Survival in Patients with Stage IV Non‐small Cell Lung Cancer
Prognostic factors which can forecast short‐term survival in patients with stage IV non‐small cell lung cancer have not been well evaluated. Characteristics of such factors may be different from those for overall survival, and would be an important eligibility criterion for clinical trials of chemot...
Autores principales: | Ando, Masahiko, Ando, Yuichi, Sugiura, Seiji, Minami, Hironobu, Saka, Hideo, Sakai, Shuzo, Shimokata, Kaoru, Hasegawa, Yoshinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926048/ https://www.ncbi.nlm.nih.gov/pubmed/10189897 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00740.x |
Ejemplares similares
-
Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule
por: Ando, Yuichi, et al.
Publicado: (1997) -
Therapeutic Drug Monitoring of Etoposide in a 14‐Day Infusion for Non‐small‐cell Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996) -
Therapeutic Drug Monitoring in 21‐Day Oral Etoposide Treatment for Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996) -
Genetic Polymorphisms of the UDP‐Glucuronosyltransferase 1A7 Gene and Irinotecan Toxicity in Japanese Cancer Patients
por: Ando, Maki, et al.
Publicado: (2002) -
Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
por: Ando, Y., et al.
Publicado: (1997)